School of Nursing and Public Health, Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa; Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal, Durban, South Africa.
Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Ann Epidemiol. 2022 Oct;74:132-139. doi: 10.1016/j.annepidem.2022.08.038. Epub 2022 Aug 14.
HIV and other sexually transmitted infections (STIs) often co-occur. However, less evidence exists on the long-term STI dynamics among persons living with HIV in sub-Saharan Africa to inform interventions. We investigated the incidence, prevalence and factors associated with STIs, starting from acute HIV infection in a cohort of South African women.
The CAPRISA002 study enrolled women with acute HIV infection and performed STI testing and treatment 1-2 times annually from 2004-2020. We estimated STI incidence, re-infection, and prevalence trends before and after antiretroviral treatment (ART). We fitted Cox regression models to identify factors associated with STIs.
We followed up 235 women (median age = 25 years, IQR 22-29) for 7.5 years (IQR 5.7-10.8). New STI and re-infection cases per 100 person-years (PYs) were 5.1 and 9.5 for Neisseria gonorrhoeae (NG), 7.4 and 14.7 for Chlamydia trachomatis (CT), 8.0 and 26.6 for Trichomonas vaginalis (TV), 7.7 and 16.7 for Mycoplasma genitalium (MG) and 25.2 and 37.3 for any STI. STI incidence, was associated with HIV log viral load (AHR = 1.24, 95% CI 1.06-1.44), active syphilis (AHR = 16.55, 95% CI 7.49-36.55), a positive HSV-2 PCR (AHR = 1.54, 95% CI 1.01-2.35), bacterial vaginosis (AHR = 1.48, 95% CI 1.01-2.18), recent regular sexual partners at enrolment (one vs none: AHR = 2.62, 95% CI 1.41-4.87; two plus vs none: AHR = 3.68, 95% CI 1.79-7.59) and age (5-year fold: AHR = 0.80, 95% CI 0.70-0.92).
The persistent STI/HIV co-infection burden among South African women highlights that early HIV diagnosis and ART initiation needs to be combined with better STI care for women and their partners to prevent HIV and STI transmission.
艾滋病毒和其他性传播感染(STI)通常同时发生。然而,在撒哈拉以南非洲,有关艾滋病毒感染者长期 STI 动态的证据较少,难以据此制定干预措施。我们调查了南非女性队列中从急性艾滋病毒感染开始的 STI 发病率、患病率和相关因素。
CAPRISA002 研究招募了急性 HIV 感染的女性,并在 2004-2020 年期间每年进行 1-2 次 STI 检测和治疗。我们评估了抗逆转录病毒治疗(ART)前后 STI 的发病率、再感染和流行趋势。我们使用 Cox 回归模型来确定与 STI 相关的因素。
我们对 235 名中位年龄为 25 岁(IQR 22-29)的女性进行了 7.5 年(IQR 5.7-10.8)的随访。每 100 人年(PYs)新发 STI 和再感染病例数分别为淋病奈瑟菌(NG)5.1 和 9.5,沙眼衣原体(CT)7.4 和 14.7,阴道毛滴虫(TV)8.0 和 26.6,生殖支原体(MG)7.7 和 16.7,任何 STI 为 25.2 和 37.3。STI 发病率与 HIV 病毒载量(AHR=1.24,95%CI 1.06-1.44)、活动性梅毒(AHR=16.55,95%CI 7.49-36.55)、单纯疱疹病毒 2 型 PCR 阳性(AHR=1.54,95%CI 1.01-2.35)、细菌性阴道病(AHR=1.48,95%CI 1.01-2.18)、入组时性伴侣数量(1 个 vs 0 个:AHR=2.62,95%CI 1.41-4.87;2 个或更多 vs 0 个:AHR=3.68,95%CI 1.79-7.59)和年龄(每增加 5 岁:AHR=0.80,95%CI 0.70-0.92)有关。
南非女性中持续存在的艾滋病毒/性传播感染合并感染负担突出表明,需要将早期艾滋病毒诊断和抗逆转录病毒治疗与妇女及其伴侣的更好的性传播感染护理相结合,以预防艾滋病毒和性传播感染的传播。